Starlims Technologies reports that is has been selected by one of the world's leading pharmaceutical companies for a $2.1 million Lims project
Starlims v10 will be implemented in the pharmaceutical company's research and development and quality assurance laboratories in North America, Europe and Asia.
"Being selected by one of the world's largest pharmaceutical companies is clearly a vote of confidence in our vision of creating a single web-based platform for laboratory informatics, covering multiple lab disciplines and reaching across the globe," said Jeff Ferguson COO at Starlims.
"We are seeing more companies standardizing their Lims across the enterprise and we believe Starlims v10 is well positioned to meet this demand".
Implementing Starlims will facilitate the sharing of scientific data and best practices across multiple laboratory sites.
The pharmaceutical customer intends to standardise on Starlims, beginning with eight sites.
One of the key considerations the customer had in selecting Starlims was its scalability, a benefit of its entirely web-based architecture.
In addition, Starlims offers multilingual and multi-time zone support, important considerations for distributed Lims implementations.
By standardising on Starlims, the company is expected to enhance regulatory compliance and traceability, by facilitating more consistent reporting and enhancing data security.
The web-based Starlims v10 system will simplify deployment, validation, scale up and upgrade of the system while reducing resource requirements for ongoing maintenance.
